1.
Long Covid: could chronic fatigue syndrome be taken seriously at last?
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format. This digital magazine brings together the latest insights and innovations from across the industry, including new discoveries, R&D and clinical trials, manufacturing technologies and supply chain management, as well as insiders’ views and in-depth analysis of the latest market and investment trends and regulatory changes affecting the industry.
2021
Abstract
Around one in ten patients who recovered from Covid-19 are experiencing post-viral infection symptoms, also referred to as long Covid syndrome. This currently widespread condition seems to mirror symptoms of post-viral myalgic encephalomyelitis (ME) aka chronic fatigue syndrome (CFS), a chronic condition that still struggles to be understood. These symptoms include: extreme tiredness, brain fog, joints ache and flu-like symptoms. While long Covid has already drawn the attention of national institutes for research and is being clinically recognised as a condition, ME sufferers feel neglected and unheard. The article aims to explain how the surge in long Covid research fundings could be a turning point for the ME community too, “even when some patients may feel it’s too little too late”.